| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9781 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8558 |
| P-glycoprotein Substrate | Non-substrate | 0.7254 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9131 |
| Non-inhibitor | 0.9650 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8371 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5682 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8168 |
| CYP450 2D6 Substrate | Non-substrate | 0.9070 |
| CYP450 3A4 Substrate | Non-substrate | 0.7003 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.7979 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8640 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9305 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5685 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9634 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7484 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9103 |
| Non-inhibitor | 0.9470 |
| AMES Toxicity | Non AMES toxic | 0.9771 |
| Carcinogens | Non-carcinogens | 0.6439 |
| Fish Toxicity | High FHMT | 0.7187 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9956 |
| Honey Bee Toxicity | High HBT | 0.6854 |
| Biodegradation | Ready biodegradable | 0.9536 |
| Acute Oral Toxicity | III | 0.9200 |
| Carcinogenicity (Three-class) | Warning | 0.4941 |